0.25
0.5
0.75
1.25
1.5
1.75
2
Alternative therapies for infectious diseases
Published on Jun 06, 20114389 Views
This presentation will be about the consequences of inappropriate use of antimicrobial agents and some of the alternative approaches to treating infectious diseases that are being investigated, like n
Related categories
Chapter list
Alternative therapies for infectious diseases00:00
Article on antimicrobial resistance02:17
Increasing resistance means02:36
A lack of antibiotics ...03:33
Alternative approaches04:56
Probiotic therapy06:13
How do probiotics work?07:30
Lactobacillus GG09:32
Urogenital tract infections (1)10:53
Urogenital tract infections (2)12:07
Urogenital tract infections (3)12:47
Clostridium difficile13:54
Human gastrointestinal tract14:31
Probiotic treatment of CDI14:57
Effect of LGG yoghurt on Clostridium difficile-associated diarrhoea (1)16:03
Effect of LGG yoghurt on Clostridium difficile-associated diarrhoea (2)16:56
Saccharomyces boulardii18:14
Human studies with S.boulardii18:51
Experiences with S.boulardii (1)20:25
Experiences with S.boulardii (2)21:16
Probiotics for CDI21:27
The ultimate probiotic21:50
Naturally-occurring antimicrobials23:17
Medicinal plants (1)24:06
Medicinal plants (2)24:43
Garlic (Allium sativum) (1)26:15
Garlic (Allium sativum) (2)26:20
Garlic (Allium sativum) (3)28:04
Garlic anti-MRSA activity in vivo28:31
Honey29:20
New Zealand tea tree32:17
Topical honey for diabetic foot ulcers32:37
Qinghaosu (1)33:40
Qinghaosu (2)33:46
The Cranberries34:34
Cranberries (Vaccinium spp.) (1)34:45
Cranberries (Vaccinium spp.) (2)35:33
Teatree road37:31
Australia37:51
Aboriginal remedy38:46
Tea tree oil39:02
Greenhouse with seedlings39:53
Tea tree field40:02
Harvesting (1)40:12
Harvesting (2)40:17
Stump40:20
Distillation40:40
View of distillation shed40:56
Distiller41:05
Tea tree mulch41:11
Tea tree (Melaleuca alternifolia) oil41:23
Components of tea tree oil42:07
Can tea tree (Melaleuca alternifolia) oil prevent MRSA?42:47
MIC/MBC (%) of TTO against skin organisms43:05
Potential for resistance to develop43:33
Formulation issues44:02
In vivo pilot study (1)44:14
In vivo pilot study (2)44:31
Decolonisation study44:34
Presence or absence of MRSA after 14 days45:03
MRSA carriage and clearance at different sites45:21
Germ tube formation45:57
Germ tube formation by C. albicans 10231 in the presence of tea tree oil46:09
Susceptibility of fluconazole susceptible C.albicansto tea tree oil gel47:00
Susceptibility of fluconazole resistant C.albicansto tea tree oil gel47:39
Cold sore pilot study (1)48:11
Cold sore pilot study (2)48:47
Cold sore pilot study results48:51
Other essential oils (1)49:26
Other essential oils (2)49:39
Bacteriophage therapy49:41
Advantages of phage therapy50:01
Bacteriophage therapy50:39
Experimental protection of mice51:29
Bacteriophage therapy - issues52:10
Bacteriophage therapy53:10
Anticancer effects53:23
Subcutaneous tumour model53:56
Antitumour effect of 10% TTO/DMSO in s.ctumour models54:24
Why haven´t these treatment options been widely explored further?55:34
Often no obvious protection ...55:44
Conclusions56:10